drugset / Trial / NCT04893239
Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies
Non-randomizedSingle-groupOpen-labelOther
Summary
This is a Phase 1, single-site, open label, exploratory study to assess delivery of LMN-201 components via enteric capsules in the gut of individuals with ostomies.
Timeline
- Start
- 2021-08-18
- Primary completion
- 2022-02-23
- Completion
- 2022-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LMN-201 Anti-toxin B VHH-1 | Unknown | — | — |
| Subject | LMN-201 Anti-toxin B VHH-2 | Unknown | — | — |
| Subject | LMN-201 Anti-toxin B VHH-3 | Unknown | — | — |